Nearly 40 million Californians now live under a law permitting physicians to prescribe life-ending medication to certain terminally ill adults, making the nation’s most populous state the fifth to authorize medical aid in dying and greatly expanding the number of Americans with access to the option.

The End of Life Option Act took effect Thursday after months of preparation by hospitals, physicians and state regulators. It applies to mentally capable California residents age 18 or older who have an incurable disease expected to cause death within six months and who can take the medication themselves. The enacted measure, originally introduced as Senate Bill 128, establishes a detailed request and documentation process and makes participation voluntary for both patients and providers.

Eligibility requires two physicians and repeated requests

A patient must make two oral requests to an attending physician at least 15 days apart and submit a written request signed in the presence of two witnesses. The attending physician must determine that the request is voluntary, confirm residency and capacity, explain alternatives including hospice and pain control, and refer the patient to a consulting physician.

The consulting physician independently confirms the diagnosis, six-month prognosis and capacity. If either doctor suspects impaired judgment from a mental disorder, the patient must be evaluated by a mental-health specialist before proceeding. The patient may withdraw at any time and must make a final attestation before ingesting the drug.

Self-administration is central to the law. A physician may prescribe but cannot inject or otherwise administer the medication. Death is recorded as resulting from the underlying terminal disease rather than suicide, protecting insurance and estate rights when the statutory process is followed.

A May guidance summary from the Cooperative of American Physicians explains that the attending doctor carries most legal duties while a consulting doctor supplies an independent second opinion. The organization urged meticulous records because errors could expose physicians to professional or legal risk.

Providers may participate, refer or opt out

No physician is required to prescribe the medication. Hospitals, medical groups, nursing facilities and hospices may prohibit employees from participating on their premises or within the scope of employment, though they must disclose relevant policies. Individual doctors who decline are not compelled by the statute to refer to a willing colleague.

That discretion means access will vary. Large health systems are adopting different policies, and rural patients may struggle to find two participating physicians. Faith-based hospitals are generally expected to opt out. Even within institutions that permit the practice, clinicians must decide whether it is consistent with their professional and moral obligations.

The California Department of Public Health’s implementation page provides the required forms and instructs physicians to submit documentation to the state. Reports are intended to permit oversight without publicly identifying patients or doctors.

UCSF clinicians examining the new framework wrote that requests for hastened death often arise from concerns about autonomy, loss of function and dignity as well as uncontrolled pain. Their 2016 clinical analysis of the California law argues that a request should begin a broader conversation about symptoms, depression, family burdens and palliative options, regardless of whether the patient ultimately proceeds.

The law emerged from a personal and political struggle

Advocates built momentum after Brittany Maynard, a 29-year-old Californian with terminal brain cancer, moved to Oregon to use that state’s Death with Dignity Act. Her public campaign gave a face to arguments that terminally ill adults should not have to leave home to control the timing of death.

Governor Jerry Brown signed the measure in October after describing his own uncertainty. A former Jesuit seminarian, Brown wrote that he considered what he would want if facing prolonged pain and concluded he could not deny that option to others. The Los Angeles Times report on his decision described months of emotional debate among patients, religious groups, disability advocates and physicians.

The California Medical Association shifted from opposition to neutrality, removing a major obstacle. Supporters argued that Oregon’s experience since 1997 showed a carefully regulated system could function without widespread abuse. Opponents warned that prognoses can be wrong, depression can distort choices and financial pressures may place vulnerable patients at risk.

A March health-policy briefing on the effective date noted that critics planned continued efforts to limit implementation and prevent expansion. The law contains a sunset provision, requiring future legislators to reconsider it after experience accumulates.

Safeguards do not end the ethical dispute

Supporters prefer the term “medical aid in dying,” emphasizing that a terminal disease is already causing death and that the patient chooses timing. Opponents often call the practice physician-assisted suicide, emphasizing the doctor’s role in supplying a lethal prescription. The vocabulary reflects fundamentally different views of medicine, autonomy and protection.

The law excludes minors, people who lack decision-making capacity and anyone unable to self-administer. Requests cannot be made through an advance directive or by a family member. Witness rules restrict people who could benefit financially, though one witness may be a relative.

Compassion & Choices’ implementation guide, produced by the principal advocacy organization supporting the law, details the requests, residency proof and state forms. Disability-rights groups and religious organizations remain concerned that formal voluntariness may not capture subtle pressure created by inadequate care, isolation or treatment costs.

Those concerns place hospice and palliative care at the center of implementation. Physicians are required to discuss comfort care, and a patient can receive an aid-in-dying prescription while enrolled in hospice. The option is not meant to replace symptom management; in practice, a careful request process may reveal needs that make the prescription unnecessary.

California changes the national scale of the debate

Oregon, Washington and Vermont have statutes permitting similar practices, while Montana’s Supreme Court has recognized a defense for physicians. California’s population exceeds those jurisdictions combined several times over. Its experience will therefore produce far more clinical encounters, institutional policies and state data.

The Coalition for Compassionate Care of California’s consumer guidance stresses that only residents with a confirmed six-month prognosis may begin the process and that no provider is obliged to take part. Those twin facts—strict eligibility and voluntary participation—will determine how broad the practical access becomes.

Cost may also shape the law’s reach. The prices of commonly prescribed barbiturates have risen sharply, and insurers are not uniformly required to cover them. Patients with resources and strong health-system support may navigate the process more easily than those who are poor, isolated or geographically distant from willing clinicians.

The first day creates a legal right, not an immediate measure of its use. Every eligible patient must still find doctors, complete the waiting period and decide whether to fill or ingest a prescription. Many may seek the medication for reassurance and never take it.

California has moved the question from legislative principle to bedside practice. The law’s success will be judged not only by whether requests are granted, but by whether choices are informed, voluntary and accompanied by high-quality care. For physicians and families, the new option does not simplify dying; it adds another consequential decision to its final months.